Sustained tetracycline‐regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno‐associated viral vector
- 21 January 2003
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 5 (6) , 493-501
- https://doi.org/10.1002/jgm.367
Abstract
Background: Viral vector delivery of neurotrophic‐expressing transgenes in the retina may retard or prevent the onset of blindness associated with photoreceptor degeneration. A key safety issue is to achieve regulated expression of these genes in the retina. The purpose of our study was to evaluate whether a single recombinant AAV‐2 (rAAV) encoding for a tetracycline (Tet)‐regulated destabilized reporter gene could provide quantitative profiles of gene regulation targeted to the rat neuroretina.Methods: A rAAV vector carrying a destabilized green fluorescent protein (dgfp) under a tet‐regulatable promoter and the tetracycline‐repressed transactivator (tTA) was generated (rAAVtetoff.dgfp) and administered intravitreally in nine Wistar rats. Retinas were monitored for 6 months using noninvasive fluorescence imaging and the animals were subjected to two cycles of doxycycline (Dox), a tetracycline analog. Eyes were ultimately examined by histology.Results: Intravitreal injection of rAAVtetoff.dgfp resulted in effective transduction of ganglion cells. Following full expression of the transgene in the absence of Dox, 95% of the GFP signal was shut down 48 h post Dox administration and the signal was undetectable 7 days later. Initial levels of GFP expression were restored 21 days after Dox administration ceased. This pattern of expression was repeated twice over a period of 6 months.Conclusions: This report demonstrates that rAAVtetoff.dgfp intravitreally injected rats displayed tight and sustained long‐term regulation of the reporter gene in ganglion cells. These findings may have important implications regarding rAAV‐mediated gene therapy using neuroprotective approaches for retinitis pigmentosa and glaucoma. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 43 references indexed in Scilit:
- Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated VirusJournal of Virology, 2002
- Baculoviral IAP Repeat-Containing-4 Protects Optic Nerve Axons in a Rat Glaucoma ModelMolecular Therapy, 2002
- Long-Term Protection of Retinal Structure but Not Function Using RAAV.CNTF in Animal Models of Retinitis PigmentosaMolecular Therapy, 2001
- Recombinant AAV-Mediated Delivery of a Tet-Inducible Reporter Gene to the Rat RetinaMolecular Therapy, 2001
- Two Animal Models of Retinal Degeneration Are Rescued by Recombinant Adeno-associated Virus-Mediated Production of FGF-5 and FGF-18Molecular Therapy, 2001
- Pharmacologically regulated gene expression in the retina following transduction with viral vectorsGene Therapy, 2001
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Factors Influencing Recombinant Adeno-Associated Virus ProductionHuman Gene Therapy, 1998
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991